Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-19

Clinical Trial Update: Comparing Treatments for Refractory Overactive Bladder: Bladder Denervation vs Botulinum Toxin Injections [Phase 4]

View source ↗

Summary

Phase 4 trial comparing bladder denervation to botulinum toxin injections for refractory overactive bladder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin A (onabotulinumtoxinA) (onabotulinumtoxinA)

Snippet

Sponsor: Bagcilar Training and Research Hospital | Conditions: Overactive Bladder Syndrome, Refractory Overactive Bladder | Phase 4 | Status: COMPLETED